FDA Issues Recall Alert for Metformin ER Products

The FDA is asking several pharmaceutical companies to voluntarily recall products containing extended-release formulations of metformin, a drug prescribed to millions of patients with type 2 diabetes.
Source: AAFP News - Category: Primary Care Source Type: news